Pitt researchers discover antibody that could be key in covid cure

By: Deb Erdley

Scientists at the University of Pittsburgh say they have isolated a tiny molecule that neutralizes the coronavirus and could be the foundation for a drug to prevent and combat covid-19, the disease caused by the virus.

Researchers from Pitt’s School of Medicine published their findings today in the journal Cell. They reported that the molecule, an antibody component that is 10 times smaller than a full-sized antibody, is the foundation of a drug known as Ab8 that has been effective in preventing and treating covid-19 in mice and hamsters.

Read the full article

Pitt to launch study of medical marijuana use to ease pain in sickle cell patients

By: Deb Erdley

Finding a way to use medical marijuana to treat sickle cell anemia will be the focus when the University of Pittsburgh School of Medicine launches a new $3 million research program. It’s part of a 10-year agreement with Goodblend Pennsylvania LLC, Pitt’s new affiliate in medical marijuana research.

State officials on Wednesday awarded the eighth and final license for medical marijuana research to the company that is part of Parallel, a privately-held multi-state cannabis company.

Read the full article

COVID-19 Update – UPMC Announces Groundbreaking Clinical Trial

Our client UPMC announced a groundbreaking clinical trial using various mixes of drugs and utilizing artificial intelligence to quickly find the most effective medicine to address COVID-19. It is the result of UPMC leading an international discussion of this approach to drug trials and the UPMC designed trial will be undertaken at UPMC and simultaneously in 13 other countries. It could yield useful results in weeks or months, not years.

To view recent media, see links below:

We highly encourage you to watch the above Physician Interviews.